Results 291 to 300 of about 53,596 (333)
Some of the next articles are maybe not open access.
2022
Malignant pleural effusions arise from neoplastic infiltration of the pleura, and are common manifestations of cancers which arise as a primary tumor of the pleura (mesothelioma) or secondary to primary cancers from other sites. Radiological investigations should always include a staging CT thorax and often will demonstrate pleural nodularity and ...
Hyams, Catherine, Maskell, Nick A
openaire +2 more sources
Malignant pleural effusions arise from neoplastic infiltration of the pleura, and are common manifestations of cancers which arise as a primary tumor of the pleura (mesothelioma) or secondary to primary cancers from other sites. Radiological investigations should always include a staging CT thorax and often will demonstrate pleural nodularity and ...
Hyams, Catherine, Maskell, Nick A
openaire +2 more sources
Current Treatment Options in Oncology, 2001
Malignant pleural effusions contribute to considerable morbidity in cancer patients and generally portend an overall poor prognosis. Treatment of malignant pleural effusions is palliative; therefore, quality of life issues, as well as the risks and benefits of the therapeutic options, become more critical.
openaire +3 more sources
Malignant pleural effusions contribute to considerable morbidity in cancer patients and generally portend an overall poor prognosis. Treatment of malignant pleural effusions is palliative; therefore, quality of life issues, as well as the risks and benefits of the therapeutic options, become more critical.
openaire +3 more sources
Management of Malignant Pleural Effusions
Drugs, 1998Malignant pleural effusions (MPEs) represent a common complication of advanced malignancies. However, adequate palliation of this highly symptomatic accompaniment to cancer can be achieved in most patients by adopting the appropriate therapy. Several options are available for the treatment of MPE.
Grossi F +4 more
openaire +3 more sources
Postgraduate Medicine, 1986
Pleural effusions are common in cancer patients, developing either from the malignant condition or from unrelated causes, such as congestive heart failure, pulmonary infarction, or infection. Diagnosis of malignant pleural effusion rests on demonstration of the presence of malignant cells in the pleural fluid or pleural biopsy specimen.
openaire +3 more sources
Pleural effusions are common in cancer patients, developing either from the malignant condition or from unrelated causes, such as congestive heart failure, pulmonary infarction, or infection. Diagnosis of malignant pleural effusion rests on demonstration of the presence of malignant cells in the pleural fluid or pleural biopsy specimen.
openaire +3 more sources
Management of malignant pleural effusions
Current Opinion in Internal Medicine, 2005Although malignant pleural effusions are a common medical problem, research into their optimal management remains sparse. The aim of this review is to summarise recent developments in this area.Talc remains the most efficacious pleurodesis agent.
Bennett, R, Maskell, NA
openaire +3 more sources
2004
The presence of pleural effusions is a common clinical problem in patients with neoplastic disease. At the time of diagnosis, approximately 15% of lung cancer patients have a pleural effusion (Naito et al. 1997).Twenty to 50% of patients with advanced or disseminated lung cancer develop a pleural effusion during the course of the ir disease (Emerson et
van Schil, Paul, Germonpré, Paul
openaire +3 more sources
The presence of pleural effusions is a common clinical problem in patients with neoplastic disease. At the time of diagnosis, approximately 15% of lung cancer patients have a pleural effusion (Naito et al. 1997).Twenty to 50% of patients with advanced or disseminated lung cancer develop a pleural effusion during the course of the ir disease (Emerson et
van Schil, Paul, Germonpré, Paul
openaire +3 more sources
Fatigue and malignant pleural effusions
BMJ Supportive & Palliative Care, 2021Dear Editors We completely agree with Twose et al 1 that until now the primary focus in both clinical practice and trials has been on interventions in malignant pleural effusions (MPEs), tailored to mitigating breathlessness and preventing admissions, with little consideration of other factors potentially of greater priority to the patient.
Avinash Aujayeb, Donna Wakefield
openaire +3 more sources
Management of Malignant Pleural Effusions
Seminars in Respiratory and Critical Care Medicine, 2008Malignant pleural effusions (MPEs) are commonly seen as complications of advanced malignancy, especially in lung cancer and breast cancer. The management will depend on the performance status of the patient, severity of the symptoms, and the primary tumor's response to systemic therapy.
Jeffrey Pollak, Marcelo Spector
openaire +3 more sources
Surgical Clinics of North America, 2002
The management of pleural effusions and, in particular, recurrent MPE require an accurate assessment of the characteristics of the pleural fluid and the relief of the patient's symptoms. Although a common problem, treatment of pleural effusions and MPE is highly variable.
openaire +3 more sources
The management of pleural effusions and, in particular, recurrent MPE require an accurate assessment of the characteristics of the pleural fluid and the relief of the patient's symptoms. Although a common problem, treatment of pleural effusions and MPE is highly variable.
openaire +3 more sources
Annals of Internal Medicine, 1978
Excerpt To the editor: To the excellent review of malignant pleural effusion by Leff, Hopewell, and Costello (Ann Intern Med88:532-537, 1978) I wish to add these practical clinical points. 1.
openaire +3 more sources
Excerpt To the editor: To the excellent review of malignant pleural effusion by Leff, Hopewell, and Costello (Ann Intern Med88:532-537, 1978) I wish to add these practical clinical points. 1.
openaire +3 more sources